Lori Fafard

591 total citations
11 papers, 119 citations indexed

About

Lori Fafard is a scholar working on Pathology and Forensic Medicine, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lori Fafard has authored 11 papers receiving a total of 119 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 2 papers in Neurology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lori Fafard's work include Multiple Sclerosis Research Studies (3 papers), Acute Lymphoblastic Leukemia research (2 papers) and Amyotrophic Lateral Sclerosis Research (1 paper). Lori Fafard is often cited by papers focused on Multiple Sclerosis Research Studies (3 papers), Acute Lymphoblastic Leukemia research (2 papers) and Amyotrophic Lateral Sclerosis Research (1 paper). Lori Fafard collaborates with scholars based in United States and Israel. Lori Fafard's co-authors include Marijean Buhse, Mark Gudesblatt, Jeffrey Wilken, Glen M. Doniger, Daniel Golan, Idit Lavi, Robert L Kane, Sourav Santra, Lily Lee and Christophe Hotermans and has published in prestigious journals such as Neurology, Multiple Sclerosis Journal and CNS Drugs.

In The Last Decade

Lori Fafard

8 papers receiving 116 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lori Fafard United States 3 99 24 21 21 9 11 119
Sarah Peacock United States 7 52 0.5× 12 0.5× 37 1.8× 10 0.5× 5 0.6× 17 147
Emmanuelle Salort France 3 189 1.9× 36 1.5× 67 3.2× 33 1.6× 8 0.9× 3 210
Svetlana Miletić Drakulić Serbia 6 46 0.5× 21 0.9× 22 1.0× 11 0.5× 1 0.1× 19 104
Breffni Keegan Italy 2 55 0.6× 50 2.1× 37 1.8× 9 0.4× 4 0.4× 2 115
Michele Gennuso Italy 4 64 0.6× 17 0.7× 32 1.5× 9 0.4× 6 0.7× 8 92
Cinzia Scandellari Italy 5 99 1.0× 14 0.6× 30 1.4× 10 0.5× 1 0.1× 8 119
Mélanie Leroy France 7 51 0.5× 28 1.2× 20 1.0× 15 0.7× 14 112
Raphaël De Paz France 4 66 0.7× 100 4.2× 32 1.5× 24 1.1× 4 0.4× 5 192
Ashok Raman United Kingdom 5 85 0.9× 16 0.7× 40 1.9× 20 1.0× 10 166
Tahir Majeed United Kingdom 8 37 0.4× 37 1.5× 98 4.7× 10 0.5× 3 0.3× 27 175

Countries citing papers authored by Lori Fafard

Since Specialization
Citations

This map shows the geographic impact of Lori Fafard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Fafard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Fafard more than expected).

Fields of papers citing papers by Lori Fafard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Fafard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Fafard. The network helps show where Lori Fafard may publish in the future.

Co-authorship network of co-authors of Lori Fafard

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Fafard. A scholar is included among the top collaborators of Lori Fafard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Fafard. Lori Fafard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Golan, Daniel, Marijean Buhse, Lori Fafard, et al.. (2020). The Association Between MRI Brain Volumes and Computerized Cognitive Scores of People with Multiple Sclerosis (4785). Neurology. 94(15_supplement).
2.
Golan, Daniel, Jeffrey Wilken, Glen M. Doniger, et al.. (2019). Validity of a multi-domain computerized cognitive assessment battery for patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 30. 154–162. 26 indexed citations
4.
Golan, Daniel, Mark Gudesblatt, Lori Fafard, et al.. (2018). Baseline cognitive function of patients with relapsing remitting multiple sclerosis is associated with therapeutic response to Natalizumab (P6.348). Neurology. 90(15_supplement). 1 indexed citations
5.
Gudesblatt, Mark, Lori Fafard, Jeffrey Wilken, et al.. (2018). Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis. CNS Drugs. 32(12). 1173–1181. 15 indexed citations
7.
Golan, Daniel, Glen M. Doniger, Marijean Buhse, et al.. (2017). The impact of subjective cognitive fatigue and depression on cognitive function in patients with multiple sclerosis. Multiple Sclerosis Journal. 24(2). 196–204. 72 indexed citations
9.
Gudesblatt, Mark, Lori Fafard, Marijean Buhse, et al.. (2016). Multiple Sclerosis: Population Analysis of Predicted Medication Adherence Behavior by Morisky Medication Adherence Scale (MMAS-8) (P2.132). Neurology. 86(16_supplement). 1 indexed citations
11.
Chahin, Salim, Laura J. Balcer, Lori Fafard, et al.. (2012). Visual Evoked Potential Latency Prolongation in MS: Correlation with Cognitive Performance on a Computerized Testing Battery (P07.260). Neurology. 78(Meeting Abstracts 1). P07.260–P07.260. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026